Lexaria Bioscience Adds Patents, Reaching 70 Worldwide
Lexaria Bioscience said it received new patents in the US, Canada and Europe covering diabetes, hypertension and epilepsy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.